Search
Recommended Products
Related Links


 

 

Informative Articles

Cataract Update
Cataract Awareness Contact Email Address: rsisk@mtco.com Category: Health & Fitness Word Count: 570 words You have permission to publish this article electronically, as long as the resource box at the end is included. Please let me know...

Diabetes Type 2 and Artificial Sweeteners
Diabetes Type 2 (adult onset) Refined carbs/sugars are actually the biggest contributing factor to type 2 diabetes--that is, the type of diabetes people develop later in life. The major contributing factor to type 2 diabetes is eating too many...

Five secrets of high blood pressure treatment
When to start the treatment for high blood pressure and how big is its real efficacy. What is the main secret of the centenarians we can use. What are the benefits of non-pharmaceutical treatment of the arterial hypertension. Thirty...

Weight Loss - Diet Change Facts
To say that Americans are obsessed with dieting is an understatement! Pick up any magazine, tune-in or turn-on any source of advertising and you're bombarded with the latest diet schemes and food fads. More often than not, they are endorsed...

What Is The Zone Diet?
The Zone Diet is one of the five most discussed diets currently being endorsed. Developed by Barry Sears, a former researcher at MIT, it is based on maintaining insulin levels by striking a balance between carbohydrates and proteins at each meal. ...

 
Google
High-dose statins lower heart attack risk

IF you suffer from stable heart disease, a higher dose of the class of cholesterol-lowering drugs known as statins might decrease the risk of heart attacks and strokes for you, a new study shows.

The study, funded by Pfizer, and called Treating New Targets, or TNT, showed that the top dose of Atorvastatin calcium decreased the risk of heart attacks and strokes in people with stable heart disease, compared to the lowest dose of the same drug.

"Atorvastatin calcium is a prescription medicine used with diet to lower cholesterol," said Dr Graham Jackson, a British-based consultant cardiologist, who was in Kuala Lumpur last week. "Lowering cholesterol levels is a proven strategy in reducing the risk of heart attack and heart disease but it is not certain what the appropriate target for lowering cholesterol should be in individuals with known heart disease. This study helped determine that. The results could potentially change the standard of care for patients with CHD."

The five-year Treating to New Targets Trial (TNT) involved 10,000 patients with established coronary heart disease and elevated LDL, or "bad" cholesterol levels. The study assessed whether patients on high-dose Atorvastatin calcium who aggressively lowered their LDL-cholesterol levels to well below the current guidelines (100 mg/dL) would experience additional cardiovascular benefits compared to Atorvastatin calcium patients who maintained their LDL-cholesterol at recommended levels.

Patients who received 80 ma doses of Atorvastatin calcium had


22 per cent fewer cardiovascular events, including CHD death, non-fatal heart attacks, resuscitated cardiac arrest, and fatal or non-fatal strokes compared to patients who took 10 mg of Atorvastatin calcium. In addition, patients treated with high- dose Atorvastatin calcium had 25 per cent fewer fatal or non-fatal strokes compared to those treated with just 10 mg of Atorvastatin calcium.

Dr Sim Kui-Hian, head of both the department of Cardiology and the Clinical Research Centre at the Sarawak General Hospital, said that the average cholesterol levels of the Malaysian population have been increasing since 1961 and the majority of Malaysians with elevated cholesterol are not at their recommended goal levels.

"This is despite the fact that coronary heart disease is the leading cause of death in Malaysia," said Dr Sim.

"Everyone hates taking medicine," he said. "But this drug is generally well tolerated. Adverse reactions usually have been mild and transient, with the most frequent adverse effects of atorvastatin being constipation, flatulence, dyspepsia and abdominal pain."

"The mainstay of treatment; besides medication, is exercise, diet and maintaining a healthy body weight," said Dr Sim. If patients are on a higher dosage of atorvastatin coupled with exercises, not smoking, maintaining correct blood pressure and controlling diabetes, coronary vascular diseases can be remarkably reduced by 80 per cent.

About the Author

www.medical-explorer.com